Research

Study finds low pain in breast cancer patients treated with palbociclib

Patients with advanced/unresectable or metastatic breast cancer treated with palbociclib combination therapy experienced low levels of baseline pain and fatigue, a recent study found. The study is apparently one of the first outside a clinical […]

UK and Baptist Health Lexington, Norton Healthcare begin recruiting participants for Phase 3 COVID-19 investigational vaccine clinical trial

The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research […]

Norton Healthcare physicians first in world to test cancer drug as COVID-19 treatment

A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor. This oral drug, manufactured by Karyopharm Therapeutics Inc. and marketed as XPOVIO, is currently approved at higher doses […]

Research is spine group’s hallmark

It’s not unusual for the presence and expertise of Norton Leatherman Spine surgeons to be requested at medical conferences around the world. This year alone, Norton Leatherman Spine physicians served as keynote speakers at spine […]

Norton Cancer Institute researching how to reduce infections linked to treating AML

Nohla Therapeutics initiates Phase 2 LAUNCH clinical trial to assess optimal dosage of innovative cell therapy for those with acute myeloid leukemia. A treatment made from umbilical cord blood is helping oncology and hematology specialists […]

Research program offers clinicians opportunities

Norton Healthcare offers a wide range of research opportunities for clinicians and their practice groups, as well as clinicians partnering from other entities. More than 850 studies were active or pending through mid-December 2017. “Norton […]

Norton Children’s Cancer Institute launches

Norton Cancer Institute and Norton Children’s Hospital, in affiliation with the University of Louisville, have founded Norton Children’s Cancer Institute to provide improved access, new programs to treat rare tumors and benign blood disorders, and […]

First patient consents to lymphoma trial

Norton Cancer Institute has enlisted the first patient ever to participate in a clinical trial studying a potential new drug to treat a type of rare lymphoma. The female patient will receive a drug designed […]

Refractory epilepsy treatments available

Patients with refractory epilepsy face a greater risk of accidents, injuries, cognitive issues, mood disorders, social difficulties and unemployment. Norton Neuroscience Institute offers a variety of treatments that can vastly improve quality of life for these patients, […]

Get Our Monthly Newsletter

Stay informed on the latest offerings and treatments available at Norton Healthcare by subscribing to our monthly enewsletter.

Subscribe

Make a Referral

Partnering with you in caring for your patients.

Refer a Patient
Are You a Patient?
Provider Spotlight

Vicki L. Owczarzak, M.D.

Vicki L. Owczarzak, M.D., is a pediatric otolaryngologist at Norton Children’s ENT & Audiology, affiliated with the UofL School of Medicine, and an assistant professor at the medical school.

Read More

Stroke Summary: Mechanical thrombectomy helps marathoner, 47, recover from stroke

The patient presented to the emergency department at Norton Audubon Hospital. He had been found at home, down in the bathroom. Incident details: May 3, 2021 47-year-old male arrived at Norton Audubon Hospital, 12:27 a.m. […]

Read Full Story

Follow-up care for kids with single ventricle anomalies and adults with Fontan circulation

Norton Children’s Heart Institute, affiliated with the UofL School of Medicine, has opened its Fontan Clinic to provide follow-up care to children and adults who have undergone the third of a three-surgery series to treat […]

Read Full Story

Additional approval makes hybrid ablation available to more atrial fibrillation patients

The Food & Drug Administration (FDA) has approved hybrid ablation as a treatment for long-standing persistent atrial fibrillation (A-fib), the most severe form of the condition affecting about 45% of A-fib patients. Hybrid ablation treats […]

Read Full Story

Newborn screening helps uncover serious and treatable disorders that aren’t clinically apparent

When a newborn metabolic screen shows the possibility of an inherited genetic disorder in an infant in the western half of Kentucky, counselors at Norton Children’s Genetics Center, affiliated with the UofL School of Medicine, […]

Read Full Story

COVID-19 to be discussed at annual R. Dietz Wolfe, M.D. Lectureship

Infectious diseases specialists Kristina A. Bryant, M.D., and Paul S. Schulz, M.D., will discuss the latest on COVID-19 at the 23rd R. Dietz Wolfe, M.D. Lectureship to be livestreamed Wednesday, Aug. 25, 2021, from 5:45 […]

Read Full Story

Search our entire site.